Noninvasive Colon Cancer Screening Option

Now that you’re 50 years young like Harry Connick, Jr., join him and Jill and take the #ScreenWithMe Challenge and talk to your healthcare provider about screening for colon cancer. Then encourage your loved ones over 50 to do the same.

When caught early, colon cancer is almost 90% treatable.*

Cologuard is a modern noninvasive screening option.

If you are like many people, you may feel anxious about getting an invasive procedure like a colonoscopy that requires unpleasant prep and time off of work.

Luckily, times have changed. Now there’s Cologuard, an easy, noninvasive test you can use at home.

 

Cologuard is indicated to screen adults of either sex, 50 years or older, who are at typical average-risk for colorectal cancer. Cologuard is not for everyone; not for high risk individuals, including those with a family history of colorectal cancer, a personal history of colorectal cancer or advanced adenoma, IBD and certain hereditary syndromes.

For Harry Connick, Jr. and his wife, Jill, cancer awareness hits close to home.

In 2012, Jill was diagnosed with breast cancer. Fortunately, the cancer was detected early through a routine screening, and now the couple is celebrating the 5-year mark of her remission.

Because of their deeply personal experience, Harry and Jill have made cancer screening awareness their mission.

A routine screening for breast cancer saved Jill’s life. When Harry turned 50, she wanted him to make colon cancer screening a top priority.

 

Take the #ScreenWithMe Challenge

Join Harry and Jill and make your pledge to ask your healthcare provider about colon cancer screening. For every pledge, $1 will be donated to colorectal cancer research and advocacy!

 

The initiative is also supported by leading colon cancer advocacy groups, including:

JOIN THE CHALLENGE

#ScreenWithMeJakeMiller
#ScreenWithMeLukeHamill
#ScreenWithMeJenniferWarren

Show your support for colon cancer screening by sharing a #ScreenWithMe badge on your Facebook page.

Screening with Cologuard is easy.

Harry took the test and can check this important task off his turning 50 to-do list. Now it’s your turn to get screened and encourage your friends over 50 to do the same.

COLOGUARD FINDS MORE THAN 9 IN 10 CANCERS AND SOME PRECANCERS.

GET MORE INFORMATION ABOUT COLOGUARD: LEARN MORE

When it comes to colon cancer, there are a lot of misconceptions.

Many people think that getting colon cancer is tied to diet and lifestyle—or that you need a family history of the disease to be at risk. Unfortunately, none of these things are true.

Facts are:

  • Your risk for colon cancer increases dramatically after the age of 50*
  • Colon cancer is the 2nd leading cause of cancer-related deaths among men and women combined
  • When caught in its earliest stages, colon cancer is 90% treatable

Harry Connick, Jr. and his wife, Jill, are touring the country to educate local communities on the importance of colon cancer screening. Join them at the next free event to learn more about why early detection matters and noninvasive options that make screening easier.

 

  • Take charge of your health while enjoying great food and lively conversation
  • Enter for the opportunity to win prizes and join Harry and Jill on stage
  • Have a chance to meet Harry after the show!

 

 

is about speaking up for yourself and taking charge of your health.

Don’t wait! Talk to your healthcare provider about your screening options, including Cologuard.

SIGN UP FOR UPDATES FROM THE NEW 50

 

Cologuard is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. A positive result may indicate the presence of colorectal cancer (CRC) or advanced adenoma (AA) and should be followed by diagnostic colonoscopy.

Cologuard is indicated to screen adults of either sex, 50 years or older, who are at typical average-risk for CRC. Cologuard is not for everyone; not for high risk individuals, including those with a family history of colorectal cancer, a personal history of colorectal cancer or advanced adenoma, IBD and certain hereditary syndromes. Positive Cologuard results should be referred to diagnostic colonoscopy. A negative Cologuard test result does not guarantee absence of cancer or advanced adenoma. Following a negative result, patients should continue participating in a screening program at an interval and with a method appropriate for the individual patient. Cologuard performance when used for repeat testing has not been evaluated or established. Rx only.

REFERENCES

*American Cancer Society. Colorectal Cancer Facts & Figures 2017-2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf. Accessed February 9, 2018.

American Cancer Society. Key statistics for colorectal cancer. http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics. Last revised January 4, 2018. Accessed January 25, 2018.

Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Accessed February 9, 2018.

 

 

For more information visit: http://www.cologuardtest.com

 

 

%d bloggers like this: